BEAT.NASDAQHeartbeam, INC
Form 4: HeartBeam Director Willem Elfrink Reports Stock Transactions
Sentiment:
SEC Form 4 Filing
Director Willem Elfrink reports acquisition and disposal of HeartBeam, Inc. stock and holdings in derivative securities.
Summary
- On June 12, 2024, Willem Elfrink, a director of HeartBeam, Inc., reported acquiring 33,185 shares of common stock at $0 and disposing of 317,982 shares.
- Following these transactions, Elfrink directly owns 106,825 shares through the Elfrink Living Trust.
- Elfrink also holds derivative securities, including options and warrants to purchase HeartBeam common stock.
- The restricted stock units (RSUs) will vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating neutral sentiment as it reports transactions without expressing opinions or forecasts.
Key Dates
| Date | Description |
|---|---|
| 12/21/2021 | Date of warrant grant with an exercise price of $6 and an expiration date of 11/11/2026. |
| 06/16/2022 | Date of warrant grant with an exercise price of $6 and an expiration date of 11/11/2026. |
| 06/12/2024 | Date of stock acquisition and disposal transactions. |
| 06/20/2024 | Date of Form 4 filing. |
| 06/12/2025 | Date of RSU vesting (or the date of the Issuer's 2025 annual meeting of stockholders). |
| 11/11/2026 | Expiration date of warrants. |
| 06/15/2031 | Expiration date of options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.